论文部分内容阅读
近年来国内不少学者认为流行性出血热(以下简称 EHF)发病机理可能与免疫反应有关,应用环磷酰胺(CY)或转移因子(TF)治疗取得了一定效果。我院从1979年起试用调整免疫功能治疗 EHF 取得了初步疗效,现报告如下:病例选择1.一般资料 1979年11月至1981年6月我院共收治 EHF 34例。在发热期或低血压期入院者30
In recent years, many domestic scholars believe that the pathogenesis of epidemic hemorrhagic fever (hereinafter referred to as EHF) may be related to the immune response, the application of cyclophosphamide (CY) or transfer factor (TF) treatment has achieved some results. Our hospital from 1979 trial to adjust the immune function to treat EHF has achieved initial effect, are as follows: Case selection 1. General information November 1979 to June 1981 in our hospital were treated EHF 34 cases. Admission to hospital during periods of fever or hypotension 30